Apyx Medical Corporation's Participation in Investor Events
Apyx Medical Corporation (NASDAQ: APYX) is excited to share details about its upcoming participation in notable investor conferences. As a leading innovator in advanced energy technology, Apyx Medical, known for its Renuvion and AYON Body Contouring System, is poised to showcase its groundbreaking products and engage with investors soon. This announcement comes as the company prepares for vital sessions that allow it to connect with market stakeholders.
Upcoming Conferences Schedule
During the month of November, Apyx Medical will participate in two significant conferences that focus on advancements in medical technology and market insights:
Craig-Hallum Alpha Select Conference
This premier conference is set for November 18. The event will take place at the Sheraton NY Times Square Hotel and will feature streamlined one-on-one meetings aimed at fostering direct communication between executives and investors. Charles Goodwin, President and CEO, along with CFO Matt Hill, will join these discussions, presenting Apyx’s strategic vision.
Canaccord Genuity MedTech, Diagnostics and Digital Health Forum
The second event, scheduled for November 20 at the Westin NY Grand Central, will also follow a one-on-one meeting format. Apyx Medical aims to engage with potential and existing investors to highlight its growth trajectory and discuss its innovative technologies in the medical field. Interested parties are encouraged to reach out to representatives from Craig Hallum and Canaccord Genuity to secure a meeting.
About Apyx Medical Corporation
Apyx Medical Corporation is at the forefront of medical technology innovation, primarily focusing on solutions that enhance surgical outcomes. The company offers revolutionary products that harness helium plasma technology. Renuvion is specifically tailored for cosmetic surgery, allowing surgeons to deliver controlled thermal energy to tissues effectively. The AYON Body Contouring System is a versatile, FDA-cleared platform that integrates various surgical features for comprehensive body contouring.
Innovative Product Offerings
Apyx Medical's technologies include Renuvion and J-Plasma, recognized for their efficiency and effectiveness as evidenced by extensive clinical documentation. The AYON system represents a significant advancement in body contouring, allowing for fat removal and tissue contraction simultaneously, delivering superior outcomes for patients. These innovations reflect Apyx's commitment to improving surgical procedures and patient satisfaction.
Investor Relations
For inquiries related to investor relations, Jeremy Feffer, Managing Director at LifeSci Advisors, is the designated contact for Apyx Medical. Those interested in connecting can reach him via phone at 212-915-2568 or through email.
Frequently Asked Questions
What is the main focus of Apyx Medical Corporation?
Apyx Medical focuses on developing advanced energy technology solutions for cosmetic and surgical applications, specifically through its Renuvion and AYON systems.
When are the upcoming investor conferences for Apyx Medical?
Apyx Medical will participate in the Craig-Hallum Alpha Select Conference on November 18 and the Canaccord Genuity MedTech, Diagnostics and Digital Health Forum on November 20.
Who will represent Apyx Medical at the conferences?
Charles Goodwin, President and CEO, and Matt Hill, CFO, will represent Apyx Medical at both conferences.
How can investors request meetings with Apyx Medical?
Investors interested in meeting with Apyx Medical representatives can contact their Craig Hallum and Canaccord Genuity representatives for arrangements.
Where can I find more information about Apyx Medical’s products?
For additional details about Apyx Medical’s innovative products, visit the official website at www.ApyxMedical.com.
